Stock Taper
SCREENER COMPARE ANY 2 STOCKS
OSUR
ORASURE TECHNOLOGIES, INC.
NASDAQ
$3.60
▼ DOWN 2.44% (-0.09)

KEY STATISTICS

Market Cap$247.85 M
52w High$4.58
52w Low$2.08
Dividend Yield30.84%
FrequencySpecial
P/E-5.22
Volume249.96K
Shares Out.68.85M

COMPANY

LEADERSHIP

Carrie Eglinton Manner
CHIEF EXECUTIVE
Carrie Eglinton Manner

COMPENSATION 2026

Salary$721,000
Stock Awards$3,394,188
Incentive Plan Pay$173,040
All Other Comp.$4,000
Total$4,292,228

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 17, 1986
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
500

PRICE TARGET

Target High$4.00
Target Low$4.00
Target Median$4.00
Target Consensus$4.00

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$31.14M
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
1987-04-08Forward3:1

PRICE

$3.60 ▼ DOWN 2.44% (−$0.09)
OVERLAYS
$3.60$3.65$3.709:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM3.60

About OraSure Technologies, Inc.

https://www.orasure.com ↗

OraSure Technologies develops and sells oral fluid diagnostic and specimen collection products globally, including COVID-19, HIV, HCV, Ebola tests, and genomic solutions for healthcare, research, and public health markets.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT ORASURE TECHNOLOGIES, INC. IS KNOWN FOR

OraQuick™ HIV Self-Test
OraQuick™ HIV Self-Test

OraSure Technologies' OraQuick™ HIV Self-Test is the first FDA-approved, at-home oral fluid rapid test for HIV-1 and HIV-2 antibodies, delivering results in 20 minutes and expanding globally, including recent approval in Canada.

COMPETITORS

COMPETITOR
ABT COMPARE
BDX COMPARE
DGX COMPARE
QDEL COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product And Services$25.34M $24.88M ▼$26.38M ▲$29.72M ▲
Other Revenues$1.75M $1.89M ▲$1.55M ▼$915K ▼

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$19.66M $18.4M ▼$18.67M ▲$20.23M ▲
Africa$4.88M $3.9M ▼$6.77M ▲$6.79M ▲
Other Foreign Countries$1.25M $2.12M ▲$1.03M ▼$1.88M ▲
Europe$1.3M $2.34M ▲$1.45M ▼$1.74M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
84
LISTED HERE
15
RANKED BY POSITION SIZE
VTI
0.00% · 2.1M
IWM
0.01% · 1.7M
SCHA
0.01% · 336.1K
DFMC
0.01% · 243.7K
R2US.L
0.01% · 164.2K
AVSC
0.01% · 121.7K
GSSC
0.04% · 109.1K
JPSE
0.05% · 81.3K
PRFZ
0.01% · 74.1K
XRSU.L
0.01% · 64.2K
RSSL
0.01% · 31.1K
SILX
0.61% · 23.4K
GERM
0.73% · 16.2K
PQ
PQSG
0.18% · 2.8K
URTY
0.00% · 2.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
69.03%
HOLDERS
264
TOP 12 OF 264 · RANKED BY POSITION SIZE
Blackrock Inc.
7.4M sh · $31.44M
Blackrock, Inc.
6.7M sh · $21.54M
Private Management Group Inc
5.4M sh · $16.27M
Neuberger Berman Group LLC
4.7M sh · $20.92M
Vanguard Group Inc
4.1M sh · $13.27M
Altai Capital Management, L.P.
3.7M sh · $12.03M
Dimensional Fund Advisors LP
3.6M sh · $11.67M
Systematic Financial Management LP
2.9M sh · $12.75M
Waddell & Reed Financial Inc
2.5M sh · $28.61M
Renaissance Technologies LLC
2.3M sh · $7.26M
Acadian Asset Management LLC
2.1M sh · $6.82M
Millennium Management LLC
2.1M sh · $6.78M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book4
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Tom Malinowski
Tom Malinowski
Sale (Full)
2021-02-23

INSIDER TRADES

★
DIRECTOR
Boyd Steven Kyle
Purchase · 3.7K shares
2026-06-26
★
DIRECTOR
Kenny John P.
Purchase · 46.1K shares
2026-06-03
★
DIRECTOR
Bertrand John D.
Purchase · 46.1K shares
2026-06-03
★
DIRECTOR
Boyd Steven Kyle
Purchase · 46.1K shares
2026-06-03

MOST RECENT ANALYST GRADES

GRADE SUMMARY
EQUAL WEIGHT 1
1 GRADES IN THE LAST 12 MONTHS
Stephens & Co. EQUAL WEIGHT

SECTORS PEERS

PEERPRICE
PRE$25.76COMPARE
PROF$6.85COMPARE
UTMD$72.77COMPARE
TARA$3.82COMPARE
STIM$2.94COMPARE
NYXH$1.60COMPARE
NTHI$4.69COMPARE
NAUT$0.89COMPARE